Close
Nordic 9Nordic 9

3B Future Health Fund (investor - Venture Capital)

Luxembourg 3bfuturehealth.com
See something wrong or missing? Let us know
Offices:Monaco
Average round investment:26.17M USD
Average number per year:2.2
Distribution: 2024 (3)2023 (1)2022 (4)2021 (2)2020 (1)
Portfolio companies: United Kingdom EpsilogenSwitzerland iOncturaUnited Kingdom NeoPhore See the entire list
Mostly invests in: United Kingdom United Kingdom (5) Health services (11)
See the entire list

Showing 3 of 11 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

3B Future Health Fund mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to 3B Future Health Fund

Name Criteria
Sweden Trill Impact
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
France Relyens Group
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland, France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Belgium EBRD
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
France IDIA Capital Investissement
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States Pfizer Venture Investments
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United Kingdom Ahren Innovation Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Northpond Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States OMX Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United States Omega Funds
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Spain Columbus Venture Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top